Foamix Pharmaceuticals Ltd. Debt Conversion, Converted Instrument, Amount
Foamix Pharmaceuticals Ltd. reported Debt Conversion, Converted Instrument, Amount of $8.10 million for the 12-month period ending 2014-12-31, per its 20-F filed 2017-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-02-21
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2014-12-31 | $8.10M 20-F · filed 2017-02-21 |